Originator: |
|
National Patient Safety Alert - MHRA
|
|
|
|
- Care Trusts
- Mental Health Trusts
- Specialists Trusts
- Learning Disabilities Trusts
- Mental Health & Social Care Trusts
- Ambulance Trusts
- Mental Health & Learning Disabilities Trusts
- Acute Trusts
- Community Trusts
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- NHS Regional Offices
- Special Health Authorities
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Territorial CMOs in Northern Ireland, Scotland & Wales
- GP - Locum
- NHS 111 and Out of hours providers
- GP Practices
- Community Pharmacy
- Primary Care Networks
- GP Practices 1
|
Title: |
|
Recall of Mexiletine hydrochloride 50mg, 100mg and 200mg Hard Capsules, Clinigen Healthcare Ltd due to a potential of underdosing and/or overdosing
|
Broadcast content: |
|
***04/08/2022. Per correction by Clinigen Healthcare Ltd, an
update was made to correct the expiry date for Mexiletine hydrochloride 50mg
Hard Capsules (batch 2111216)**** Clinigen Healthcare Ltd is initiating a recall of three batches of Mexiletine hydrochloride hard capsules due to a potential risk of underdose or overdose, which could have consequences for the safety of patients.
This National Patient Safety Alert contains further information and actions for providers.
|
Additional information: |
|
NHS England Regional Teams: please cascade this alert to Community Pharmacy contractors.
|
Action underway deadline: |
|
08-Aug-2022
|
Action complete deadline: |
|
12-Aug-2022
|